Reply : considerations on the evaluation under field conditions of a rapid test for detection of IgM and IgG antibodies against SARS-CoV-2
| Errataetall: |
CommentOn: Rev Peru Med Exp Salud Publica. 2020 Dec 2;37(3):571-572. - PMID 33295564 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Revista peruana de medicina experimental y salud publica - 37(2020), 3 vom: 02. Dez., Seite 573-574 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Réplica: consideraciones sobre la evaluación en condiciones de campo de una prueba serológica rápida para detección de anticuerpos IgM e IgG contra SARS-CoV-2 |
|---|
| Beteiligte Personen: |
Vidal-Anzardo, Margot [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 17.12.2020 Date Revised 17.12.2020 published: Print CommentOn: Rev Peru Med Exp Salud Publica. 2020 Dec 2;37(3):571-572. - PMID 33295564 Citation Status MEDLINE |
|---|
| doi: |
10.17843/rpmesp.2020.373.5918 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318610639 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318610639 | ||
| 003 | DE-627 | ||
| 005 | 20231225165714.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.17843/rpmesp.2020.373.5918 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1061.xml |
| 035 | |a (DE-627)NLM318610639 | ||
| 035 | |a (NLM)33295565 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Vidal-Anzardo, Margot |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reply |b considerations on the evaluation under field conditions of a rapid test for detection of IgM and IgG antibodies against SARS-CoV-2 |
| 246 | 3 | 3 | |a Réplica: consideraciones sobre la evaluación en condiciones de campo de una prueba serológica rápida para detección de anticuerpos IgM e IgG contra SARS-CoV-2 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.12.2020 | ||
| 500 | |a Date Revised 17.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Rev Peru Med Exp Salud Publica. 2020 Dec 2;37(3):571-572. - PMID 33295564 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Immunoglobulin M |2 NLM | |
| 700 | 1 | |a Solis, Gilmer |e verfasserin |4 aut | |
| 700 | 1 | |a Solari, Lely |e verfasserin |4 aut | |
| 700 | 1 | |a Minaya, Gabriela |e verfasserin |4 aut | |
| 700 | 1 | |a Ayala-Quintanilla, Beatriz |e verfasserin |4 aut | |
| 700 | 1 | |a Astete-Cornejo, Jonh |e verfasserin |4 aut | |
| 700 | 1 | |a Luque-Aguilar, Amparo |e verfasserin |4 aut | |
| 700 | 1 | |a Jorge, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Rojas, Nancy |e verfasserin |4 aut | |
| 700 | 1 | |a Cardenas, Fanny |e verfasserin |4 aut | |
| 700 | 1 | |a Soto, Alonso |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista peruana de medicina experimental y salud publica |d 2007 |g 37(2020), 3 vom: 02. Dez., Seite 573-574 |w (DE-627)NLM203579194 |x 1726-4642 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2020 |g number:3 |g day:02 |g month:12 |g pages:573-574 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.17843/rpmesp.2020.373.5918 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2020 |e 3 |b 02 |c 12 |h 573-574 | ||